Correlation Between Conduit Pharmaceuticals and OKYO Pharma
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and OKYO Pharma Ltd, you can compare the effects of market volatilities on Conduit Pharmaceuticals and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and OKYO Pharma.
Diversification Opportunities for Conduit Pharmaceuticals and OKYO Pharma
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Conduit and OKYO is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and OKYO Pharma go up and down completely randomly.
Pair Corralation between Conduit Pharmaceuticals and OKYO Pharma
Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 6.07 times more return on investment than OKYO Pharma. However, Conduit Pharmaceuticals is 6.07 times more volatile than OKYO Pharma Ltd. It trades about 0.12 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.02 per unit of risk. If you would invest 1.00 in Conduit Pharmaceuticals on September 6, 2024 and sell it today you would earn a total of 0.08 from holding Conduit Pharmaceuticals or generate 8.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 51.56% |
Values | Daily Returns |
Conduit Pharmaceuticals vs. OKYO Pharma Ltd
Performance |
Timeline |
Conduit Pharmaceuticals |
OKYO Pharma |
Conduit Pharmaceuticals and OKYO Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Conduit Pharmaceuticals and OKYO Pharma
The main advantage of trading using opposite Conduit Pharmaceuticals and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.Conduit Pharmaceuticals vs. Candel Therapeutics | Conduit Pharmaceuticals vs. Cingulate Warrants | Conduit Pharmaceuticals vs. Unicycive Therapeutics | Conduit Pharmaceuticals vs. Cardio Diagnostics Holdings |
OKYO Pharma vs. Candel Therapeutics | OKYO Pharma vs. Anebulo Pharmaceuticals | OKYO Pharma vs. Cingulate Warrants | OKYO Pharma vs. Unicycive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |